John A Fleishman1, Anne K Monroe, Cindy C Voss, Richard D Moore, Kelly A Gebo. 1. *Center for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality, Rockville, MD; †Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD; and ‡Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD.
Abstract
BACKGROUND: Costs of care for persons living with HIV have been high historically. Cost estimates based on data from 1 health care site may underestimate total expenditures; using insurance claims avoids this limitation. We used Medicaid claims data to comprehensively assess payments for care for persons living with HIV between 2006 and 2010. METHODS: Five sites from the HIV Research Network (HIVRN) provided information on patients with Medicaid coverage. Medicaid data were obtained from the sites' states (MD, NY, and MA) and 3 surrounding states and matched to HIVRN medical record-based data. Individuals less than 18, those with Medicare, and those in Medicaid managed care plans were excluded. Medicaid and HIVRN data were compared to ascertain concordance in capturing any inpatient event and any antiretroviral (ART) medication use. RESULTS: Of 6892 unique HIVRN identifiers, 6196 (90%) were linked to Medicaid data. The analytic sample included 11,341 person-years of Medicaid claims data from 3695 individuals in fee-for-service (FFS) programs. The mean annual FFS payment for all services was $47,434; mean annual FFS payment for only medical services was $38,311. Concordance between Medicaid and HIVRN data was excellent for ART use, but HIVRN data did not record a substantial proportion of years in which Medicaid recorded inpatient use. CONCLUSIONS: Estimated Medicaid payment amounts in this study are higher than some previous estimates. More complete capture of expensive inpatient hospitalizations in Medicaid data may partially explain this finding. Although inpatient care and ART medications contribute the most, expenditures for nonmedical services are substantial.
BACKGROUND: Costs of care for persons living with HIV have been high historically. Cost estimates based on data from 1 health care site may underestimate total expenditures; using insurance claims avoids this limitation. We used Medicaid claims data to comprehensively assess payments for care for persons living with HIV between 2006 and 2010. METHODS: Five sites from the HIV Research Network (HIVRN) provided information on patients with Medicaid coverage. Medicaid data were obtained from the sites' states (MD, NY, and MA) and 3 surrounding states and matched to HIVRN medical record-based data. Individuals less than 18, those with Medicare, and those in Medicaid managed care plans were excluded. Medicaid and HIVRN data were compared to ascertain concordance in capturing any inpatient event and any antiretroviral (ART) medication use. RESULTS: Of 6892 unique HIVRN identifiers, 6196 (90%) were linked to Medicaid data. The analytic sample included 11,341 person-years of Medicaid claims data from 3695 individuals in fee-for-service (FFS) programs. The mean annual FFS payment for all services was $47,434; mean annual FFS payment for only medical services was $38,311. Concordance between Medicaid and HIVRN data was excellent for ART use, but HIVRN data did not record a substantial proportion of years in which Medicaid recorded inpatient use. CONCLUSIONS: Estimated Medicaid payment amounts in this study are higher than some previous estimates. More complete capture of expensive inpatient hospitalizations in Medicaid data may partially explain this finding. Although inpatient care and ART medications contribute the most, expenditures for nonmedical services are substantial.
Authors: Kelly A Gebo; John A Fleishman; Richard Conviser; James Hellinger; Fred J Hellinger; Joshua S Josephs; Philip Keiser; Paul Gaist; Richard D Moore Journal: AIDS Date: 2010-11-13 Impact factor: 4.177
Authors: Bruce R Schackman; John A Fleishman; Amanda E Su; Bethany K Berkowitz; Richard D Moore; Rochelle P Walensky; Jessica E Becker; Cindy Voss; A David Paltiel; Milton C Weinstein; Kenneth A Freedberg; Kelly A Gebo; Elena Losina Journal: Med Care Date: 2015-04 Impact factor: 2.983
Authors: Baligh R Yehia; Kelly A Gebo; Perrin B Hicks; P Todd Korthuis; Richard D Moore; Michelande Ridore; William Christopher Mathews Journal: AIDS Patient Care STDS Date: 2008-12 Impact factor: 5.078
Authors: Baligh R Yehia; John A Fleishman; Allison L Agwu; Joshua P Metlay; Stephen A Berry; Kelly A Gebo Journal: J Acquir Immune Defic Syndr Date: 2014-09-01 Impact factor: 3.731
Authors: Jack C Rusley; Anne Monroe; Pamela Matson; Kelly A Gebo; Bareng Aletta Sanny Nonyane; Cynthia S Minkovitz; Allison Agwu; Mark Emerson; Richard Moore; Richard Rutstein; Judith Aberg; Ank Nijhawan; Stephen Boswell; Renata Sanders Journal: AIDS Patient Care STDS Date: 2019-03 Impact factor: 5.078
Authors: Chelsea E Canan; Geetanjali Chander; Anne K Monroe; Kelly A Gebo; Richard D Moore; Allison L Agwu; G Caleb Alexander; Bryan Lau Journal: J Acquir Immune Defic Syndr Date: 2018-07-01 Impact factor: 3.731
Authors: Sarah E Macinski; Jayleen K L Gunn; Mona Goyal; Charles Neighbors; Rajeev Yerneni; Bridget J Anderson Journal: Am J Epidemiol Date: 2020-05-05 Impact factor: 4.897
Authors: Benjamin Enns; Jeong Eun Min; Dimitra Panagiotoglou; Julio S G Montaner; Bohdan Nosyk Journal: BMC Health Serv Res Date: 2019-09-03 Impact factor: 2.655